This is a snippet of the transcript, sign up to read more.
We were able to track longitudinal data, meaning we could see individual patients' purchasing patterns over time and how much product they were buying. This allowed us to track product utilization. Generally, there was good compliance. I say "generally good compliance" because the main concern is the 1% of the time when the product fails. 99% of the time, the products work fine. However, the 1% failure is devastating and traumatic.
This is a snippet of the transcript, sign up to read more.
We observed interesting behavior. At home, people might use the bag for longer periods because they are comfortable. But when they go out, they change it frequently to avoid failure during dinner, outings, or vacations. Consumer surveys showed that, for example, with a one-piece system in Europe, people might wear it for one and a half days. However, if going out for dinner, they replace it in the afternoon to ensure no failure. On vacation, utilization might be higher to avoid ruining the experience.
This is a snippet of the transcript, sign up to read more.
Compliance was generally good, and people weren't hoarding bags. If reimbursement allowed for 12 bags a month, people used about 12 on average, maybe 10 some months, maybe 14 others, but it averaged out.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research